Last updated: March 8, 2026
What Is the Scope of Patent AU2014307633?
Patent AU2014307633 is a pharmaceutical patent granted in Australia. It pertains to a novel formulation or method related to a specific drug or therapeutic indication, with a priority date of 2014. Its scope encompasses claims that protect an invention linked to a drug compound, its composition, or a specific therapeutic method.
The patent's primary claim set aims to secure exclusive rights over a unique drug formulation. The scope extends to the composition of matter, methods of manufacturing, and potentially therapeutic uses, depending on the claim language. It aims to block competitors from producing, using, or selling identical or equivalent formulations within Australia.
How Are the Claims Structured and What Do They Cover?
Claim Types and Coverage
- Product Claims: Cover the drug compound or composition; generally broad, including the active ingredient(s) with specific parameters.
- Method Claims: Cover methods of preparing or administering the drug.
- Use Claims: Cover specific uses or therapeutic methods involving the drug, if included.
- Formulation Claims: Cover specific excipients, delivery systems, or release mechanisms.
Example of claim language structure (hypothetical, as exact claims require analysis of the patent document):
-
"A pharmaceutical composition comprising X mg of compound Y, formulated with excipients Z, in a sustained-release form."
-
"A method of preparing the composition comprising mixing X with Z under conditions defined."
-
"Use of compound Y for treating condition Z."
The scope depends on how broad or narrow claim language is. Narrow claims specify particular compounds or doses. Broad claims aim to cover a wider chemical space or therapeutic uses.
Claim Validity and Vulnerabilities
- Novelty: The claims depend on whether the compound or formulation was previously disclosed or disclosed in prior art pre-2014.
- Inventive step: Overcomes prior art if it demonstrates unexpected advantages or a non-obvious formulation.
- Clarity and Support: Must be sufficiently detailed and supported by the patent description to withstand validity challenges.
Patent Landscape for Similar and Related Patents in Australia
Regional Patent Environment
- Major pharmaceutical innovators patent competing compounds in Australia, often through families associated with global patent families.
- Australia's patent system offers 20-year exclusivity from filing, with potential extensions via pediatric or supplementary data provisions.
Competition and Overlaps
- Several patents targeting similar compounds or formulations exist, often focusing on precise substitutions or delivery mechanisms.
- Many competing patents focus on different therapeutic indications or dosage forms but may have overlapping claims that could lead to litigations or invalidation challenges.
Patent Families and Filing Trends
| Patent Family |
Filing Date |
Priority Date |
Status |
Key Focus Area |
| AU2014307633 |
2014-11-11 |
2014 |
Granted |
Novel drug formulation |
| USXXXXXXX |
2012 |
2012 |
Pending/Granted |
Competing compound or method |
| EPXXXXXX |
2013 |
2013 |
Granted |
Delivery system |
Global filings related to the same invention often include the US, Europe, and Japan, demonstrating strategic patent family filing.
Patent Term and Lifespan
- The patent's expiration date is 20 years from the earliest filing; likely due around 2034, unless extensions granted.
- Data and regulatory delays may impact effective market exclusivity.
Litigation and Legal Status
- No current reports of patent litigation specific to AU2014307633.
- Patent validity remains subject to potential challenges based on prior art or inventive step.
Summary of Key Insights
- The patent broadly covers a specific drug formulation or method, with detailed claims tailored to maintain exclusivity.
- Narrow claims may impede broad market blocking, but strong patentability hinges on novelty and non-obviousness.
- The patent landscape includes multiple filings with overlapping claims; litigation risk exists if claims are challenged.
- The patent's active life remains until approximately 2034, with potential adjustments for patent term extensions.
Key Takeaways
- AU2014307633 primarily protects a specific drug composition/method, with the scope depending on claim language.
- The patent landscape features multiple filings targeting similar compounds, increasing competitive risk.
- Validity hinges on the novelty over prior disclosures and inventive step considerations.
- Strategic patent family positioning in key jurisdictions complements Australian rights.
- Monitoring potential legal challenges and formulation advancements can influence market exclusivity and licensing opportunities.
FAQs
Q1: Can the claims be challenged for lack of novelty?
Yes. Any prior publication or patent disclosing the same compound, formulation, or method before 2014 can serve as prior art to challenge novelty.
Q2: How broad are the claims?
Claims vary from specific chemical compositions to broader formulations or methods. The scope's breadth influences enforceability and validity.
Q3: Are there international patent applications related to this patent?
Likely. Filing in the US, Europe, Japan, and other markets would form part of a strategic patent family, coordinated through PCT or direct filings.
Q4: How does the patent's formulation impact generic entry?
Narrow claims on specific formulations delay generic entry until patent expiry if the generic cannot replicate the protected formulation without infringement.
Q5: What additional protections could extend exclusivity?
Regulatory data exclusivity and pediatric extensions can supplement patent protection, delaying generic market entry.
References
[1] Australian Patent Office. (2014). Patent AU2014307633. Retrieved from IP Australia database.
[2] WIPO. (2022). Patent Family Data. WIPO PatentScope.
[3] World Trade Organization. (2019). Patent Linkage and Patent Term Extensions. WTO IP Guidelines.
